Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026)

Koninklijke Philips (PHG) recorded quarterly Liabilities and Shareholders Equity of $31.9 billion in Q1 2026, up 1.78% quarter-over-quarter from $31.4 billion in Q4 2025, and up 11.71% on a YoY basis from $28.6 billion in Q1 2025.

Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Koninklijke Philips' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $31.9 billion for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 11.71% year-over-year to $31.9 billion; the TTM figure through Mar 2026 stood at $123.9 billion (up 35.78% YoY), while the FY2025 annual figure was $31.4 billion, up 1.29% from the prior year.
  • Liabilities and Shareholders Equity was $31.9 billion for Q1 2026 at Koninklijke Philips, up from $31.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $34.7 billion in Q2 2022 to a low of $28.6 billion in Q1 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $31.4 billion across 5 years, with a median of $31.4 billion in 2025.
  • The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity fell 11.6% in 2022, then advanced 11.71% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $31.3 billion in 2022, then climbed by 1.05% to $31.6 billion in 2023, then retreated by 2.13% to $31.0 billion in 2024, then gained by 1.29% to $31.4 billion in 2025, then gained by 1.78% to $31.9 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $31.9 billion (Q1 2026), $31.4 billion (Q4 2025), and $30.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 22.72 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 31.92 Bn
Dec 31, 2025 31.36 Bn
Sep 30, 2025 30.79 Bn
Jun 30, 2025 29.86 Bn
Mar 31, 2025 28.58 Bn
Dec 31, 2024 30.96 Bn
Jun 30, 2024 31.74 Bn
Dec 31, 2023 31.64 Bn
Jun 30, 2023 32.13 Bn
Dec 31, 2022 31.31 Bn
Jun 30, 2022 34.67 Bn
Dec 31, 2021 35.42 Bn
Jun 30, 2021 34.93 Bn
Dec 31, 2020 33.04 Bn
Jun 30, 2020 30.27 Bn
Dec 31, 2019 29.90 Bn
Jun 30, 2019 29.61 Bn
Dec 31, 2018 29.70 Bn
Jun 30, 2018 29.63 Bn
Dec 31, 2017 29.81 Bn